Effect of Simvastatin Treatment on Vaso-occlusive Pain in Sickle Cell Disease

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

May 31, 2015

Study Completion Date

June 30, 2015

Conditions
Sickle Cell Disease
Interventions
DRUG

Simvastatin

40 mg, orally, once daily for 3 months

Trial Locations (1)

94609

Children's Hospital and Research Center Oakland, Oakland

All Listed Sponsors
collaborator

University of California, Los Angeles

OTHER

lead

UCSF Benioff Children's Hospital Oakland

OTHER

NCT01702246 - Effect of Simvastatin Treatment on Vaso-occlusive Pain in Sickle Cell Disease | Biotech Hunter | Biotech Hunter